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Abstract
Background: Exercise referral schemes within clinical populations may offer benefits for inactive and sedentary
individuals, and improve and aid treatment of specific health disorders. This systematic review aims to provide an
overview, and examine the impact, of exercise referral schemes in patients with cardiovascular, mental health, and
musculoskeletal disorders. This review focuses on populations within the United Kingdom (UK) only, with an aim to
inform national exercise referral policies and guidelines.
Method: Data was collected from specific sources using validated methodology through PRISMA. Systematic
searches were performed using Locate, PubMed, Scopus and Pro Quest: Public Health databases. Thirteen studies
met inclusion criteria set for each sub group. This included that all studies aimed to prevent, observe, or decrease
ill-health relating to the disorder, participants over the age of sixteen, and health disorders and outcomes were
reviewed. All studies were conducted in the UK only.
Results: In the 13 articles, a variety of modes and types of exercise were utilised. One-to-one supervised exercise
sessions based in a gym environment were most frequently employed. Results showed that longer length schemes
(20+ weeks) produced better health outcomes, and had higher adherence to physical activity prescribed, than
those of shorter length (8–12 weeks). In patients referred with cardiovascular disorders, cardiovascular-related
measures showed significant decreases including blood pressure. Schemes increased physical activity levels over
the length of scheme for all disorders.
Conclusion: Longer length schemes (20+ weeks) improved adherence to physical activity prescribed over the
course of the scheme, and could support longer term exercise adherence upon completion, however additional
research on larger samples should examine this further. An implication is that schemes currently recommended in
guidelines do not tailor programmes to support long term adherence to exercise, which must be addressed. There
is currently a lack of research examining programmes tailored to suit the individual’s health conditions thus further
research might allow providers to tailor delivery and build upon policy recommendations in the UK.
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Background
Frequent physical activity (PA) and exercise are both
widely acknowledged to be effective in the prevention,
management and treatment of many chronic health disor-
ders [1–4]. PA is expressed as any bodily movement which
is created by skeletal muscles that demands energy expend-
iture [5]. Whereas, exercise comprises of a sequence of
physical activities that are repetitive and structured, with
having the final intention of maintaining or improving
physical fitness [6]. A body of research has documented
the positive effects PA and exercise have on physiological
health and psychological wellbeing [2], including enhanced
mood [7], pain reduction [8], reduced risk of falls [9], de-
creased blood pressure (BP) and resting heart rate [9, 10],
reduced depression [1, 11] and reduced anxiety [12].
Population PA levels are decreasing, creating serious
repercussions for the population’s health and resulting in
an epidemic of non-communicable diseases [10, 13],
with an intensifying importance internationally to sup-
port the promotion of healthier lifestyles and increase in
PA [14, 15]. Insufficient levels of PA are one of the major
risk factors for death worldwide [16]. Within the UK,
approximately 20 million adults are defined as physically
inactive, increasing their risk of cardiovascular diseases
(CVD), obesity, and premature death [17]. The impact
of physical inactivity cost the National Health Service
(NHS) £900 million in 2015 [18], which has risen to £1.2
billion in 2017 [17].
The management and treatment of many chronic disor-
ders with PA can be built into public health pathways via
exercise referral schemes (ERS). These schemes were first
created in the 1990s in primary care settings to facilitate
the promotion of increasing PA [19, 20]. These schemes
work differently to other clinical exercise interventions as
they are often employed in a non-clinical environment.
This can be advantageous for individuals who may have
difficulties in access to hospitals or other clinical environ-
ments which may not be local. However, they may be dis-
advantageous to individuals due to them typically being
delivered in a leisure/gym environment, previously discov-
ered to be a barrier to adherence in ERS [21].
ERS intended aims include increasing PA levels and
thus potentially produce positive impacts on health out-
comes [22]. Referrals are usually prepared by primary
care professionals (including general practitioners (GPs),
nurses, physiotherapists, and condition-specific special-
ists) to third party service providers to increase PA
levels and thus improve health disorders. Participant
engagement through personalised exercise programmes
at leisure and sports centres are the usual path [2, 22].
Schemes habitually last 10–12 weeks within England
and Ireland [2, 23]. Within Wales, the National Exercise
Referral Programme lasts 16 weeks, which has been shown
to be more cost-effective than schemes that conclude prior
to this [24]. The National Institute for Health and Care Ex-
cellence (NICE) [22], who published the guidelines Physical
Activity: Exercise Referral Schemes [Public health guideline
PH54], recommend schemes last for at least 12 weeks.
However, there is no emphasis on schemes to last longer
than the recommended minimum of 12 weeks.
Research regarding the types of activities offered on
schemes and participation rates is mixed [25]. The type
and mode of physical activities which are offered in ERS
include one-to-one supervised gym based exercise sessions
which incorporate both cardiovascular and resistance exer-
cises into one exercise programme, group aerobic classes,
swimming, walking groups, and chair-based exercise ses-
sions [2]. Within current ERS policy [22], there are no
guidelines on the type and mode of exercise which should
be encouraged within ERS. Therefore, there is demand for
research to examine the various algorithms exercise which
are effective in ERS, along with adherence to ERS.
At present, the literature reviewing the impact of ERS
is considered to be inadequate [22, 25] due to findings
revealing inconsistent and weak evidence regarding the
impact of ERS on PA levels, wellbeing, quality of life or
health outcomes [2, 26]. Conversely, the success of ERS
is highly swayed by uptake to schemes and adherence
[27]. Important evidence of the efficacy of ERS has been
generated [2, 21, 26, 28], although effectiveness is influ-
enced by the quantity of referrals who participate until
completion.
There are many studies currently available which review
participants with specific health disorders, however many
lack strong evidence to support the effectiveness of ERS
on specific health disorders [27]. Thus, NICE [22] sug-
gested that, in addition to research examining the impact
of ERS generally, further research is needed regarding the
impact of ERS in improving specific health outcomes in
specific populations. It is vital that the bridge between re-
search and policy is built, to understand the role of ERS to
manage specific health disorders.
There are many reasons for referral into an ERS. Health
conditions can be categorised according to the ICD-10
Version: 2010 [29], which include cardiovascular, meta-
bolic, respiratory, musculoskeletal, mental health, digestive
and behavioural disorders.
ERS are often recommended in various specific health
conditions including those with cardiovascular (CV),
mental health (MH), and musculoskeletal (MSK) disorders.
Despite different aetiologies, symptoms, and co-morbidities
of these disorders, the effectiveness of ERS has often
been judged based upon their overall impact in popula-
tions undertaking them, as opposed to their effective-
ness of those with specific disorders, or upon specific
health outcomes [2]. As such, there is a need to exam-
ine the effectiveness of ERS in this regard also. Review-
ing the effectiveness of ERS in specific disorders and
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upon specific outcomes, could inform guidelines on
management and treatment.
At present, the NHS is under pressure [30]. Referral of
more patients into ERS may have the potential to reduce
this burden. CV disorders affect approximately 5.9 million
people within the UK, with healthcare costs estimated at
£9 billion each year [31]. CV disease costs the UK econ-
omy an estimated £19 billion each year [31]. The cost of
hypertension can be as high as £2040 per person, with a
heart attack costing the NHS £2390 per incidence. MH
disorders are one of the major causes of overall disease
burden worldwide, with the most predominant MH dis-
order being depression [32]. The cost to the economy is
estimated £105 billion a year according to the NHS [33].
MSK disorders affect approximately 23 million people in
the UK, with over 30 million work days are lost each year
as a result [34].
As noted, a lack of PA increases the risk of non-com-
municable diseases [13, 17]. For many of those disor-
ders mentioned, patients will often visit their GP as a
first point of contact. If exercise can be used as a man-
agement tool to aid health disorders, then this could
impact GP visits and reduce them over time. It costs
the NHS £242 per hour of patient contact [30]. To put
an individual through a 12-week ERS scheme costs ap-
proximately £225. If ERS are found to be effective in im-
proving health outcomes, then the NHS could reduce
money spent on GP contact time, and invest into referring
people into exercise [35].
At present, there is a lack of evidence to support the
effectiveness of ERS. In their guidelines in 2014, NICE
[22] suggested that this lack of evidence is a critical point
for consideration, as there had been to that point a lack of
progress within research to increase the evidence-base for
these schemes [22]. It has been suggested that ERS stake-
holders at present have conflicting and inconsistent views
of the evidence which can influence funding opportunities
[22, 36]. A previous systematic review of the effects of
ERS on PA and improving health outcomes found that
there was still uncertainty as to their effectiveness [2]. This
review suggested that further research is required to
separately report outcomes, and review disorder-specific
populations. This systematic review aims to meet these
suggestions, with an update on current research since
2011, to improve recommendations and to advance NICE
policy recommendations. Thus, the main aim of this sys-
tematic review is to examine the effects of ERS in persons
with CV, MH, and MSK disorders within the UK.
Method
This review follows the guidelines set out by the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) [37]. A PRISMA flow diagram can be seen
in Fig. 1.
Search strategy
This systematic review was based on a literature search
in each of the following databases: Locate, PubMed,
Fig. 1 PRISMA flowchart detailing flow of studies through the review
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Scopus and Pro Quest: Public Health. To maximise the
specificity, initial searches used “exercise referral schemes”
and “adherence”, along with sub-group specific words
(“cardiovascular”, “mental health”, “depression”, “anxiety”,
“musculoskeletal”). A title and abstract search was con-
ducted primarily, with restrictions on publication dates
(post January 2011 due to Pavey, et al. [2] reviewing for
CV and MH disorder sub-groups, and an open search for
the MSK disorder due to lack of research included in that
review within this sub-group). During the primary search
of title and abstract, one reviewer initially ruled out
clearly irrelevant titles and abstracts. Articles were
UK-based studies due to the potential impact of this re-
view on changing UK ERS policies and guidelines. Dur-
ing the next stage, two reviewers then independently
screened the remaining titles and abstracts. During the
final stage, full abstracts categorised as potentially eligible
for inclusion were screened by consensus of three re-
viewers and disagreements were resolved by consensus.
Risk of bias criteria came from previous instruments
which assessed the quality or risk of bias, which reduced
any bias [38, 39].
Inclusion criteria
Papers which were included met the following conditions:
(a) One of the main aims being prevention, observation,
or treatment of the health condition (including (1) CV
disorders, (2) MH disorders, and (3) MSK disorders);
(b) participants were over the age of sixteen; (c) health
conditions and their outcomes were reviewed; and, (d)
UK-based studies only, due to the potential of this
paper possibly influencing UK ERS policy. Studies were
included regardless of the study design, as the primary
aim was to provide an updated review of the ERS to inform
policy and guidelines; (e) utilised outcome measures which
measured CV, MH and MSK conditions of participants.
Exclusion criteria
Papers were excluded if: (a) Articles were not published
in a peer reviewed journal (annual reports, editorials,
systematic reviews/meta-analyses, opinions and studies
available only as abstracts were also excluded); (b) If
participants were below the age of sixteen, as guidelines
states people must be over 16 years to participate
within ERS [2]; and, (c) articles dated before January
2011 for CV and MH disorders, but open search for
MSK. The reason for limiting search for CV and MH is
due to the systematic review conducted by Pavey, et al.,
when the most recent updated review was conducted.
This review is an update on current research since 2011,
to improve recommendations and to advance NICE policy
recommendations.
Results
The search strategy detected initially 763 potentially
relevant articles within the literature search. With this,
137 duplicates were removed. From this, 78 articles were
screened due to their titles and abstracts being relevant,
with then a further 64 excluded for not meeting inclu-
sion criteria. Reasons for exclusion at this point included
if they did not have the main aims of prevention, ob-
servation, or treatment of the health condition. From
this, 56 articles were selected for further analysis by
reading each full text. Of those, 13 studies were selected
for inclusion (Fig. 1: flow of studies through search and
screening).
Characteristics of studies and results
In Tables 1, 2 and 3, the characteristics and results from
each of the studies are described and explained for CV,
MH, and MSK disorders.
Results for cardiovascular disorders’ sub-group
All ten articles collected quantitative data. Four rando-
mised controlled trials (RCTs) were included in the review
for CV disorders. One RCT compared standard ERS to a
self-determination theory (SDT)-based ERS [25], two RCTs
compared ERS to usual care [40, 41], and one compared to
baseline [24]. A retrospective study reviewed the costs and
benefits associated with ERS [42]. Another study compared
the characteristics of adherers and non-adherers [43]. One
observational cohort study [44] reviewed outcomes be-
tween time points: baseline, 6 months, and 12 months,
whilst another examined the success of ERS in order to
predict completion [45]. Another study used an explora-
tory approach to review the role of autonomy support
upon entering ERS [46]. Whilst a final paper conducted an
evaluation of ERS compared to community-based exercise
and a continuously-monitored exercise programme [47].
CV disorder-related outcomes
Four studies contained participants with coronary
heart disease (CHD) or who were at increased CHD
risk [24, 25, 40, 41]; six studies with CV disease or at
increased CV disease risk [41, 43, 45–47]; and one
study included participants with hypertension [42]. Even
though various designs were employed, body mass index
(kg/m2) or body mass decreased [25, 45, 47] (no results of
BMI in one study [43]), with one study showing a signifi-
cant difference of 0.24 kg/m2 (p < 0.05) compared to base-
line [25]. Webb, et al. [47] found reductions in BMI
compared to baseline and control. Mills, et al. [45] did not
report on BMI, but did report on body mass, finding sig-
nificant reductions in body mass (p < 0.001) compared to
baseline, with 33.3% of participants achieving weight loss.
Both systolic and diastolic Blood pressure was recorded
in four studies [25, 43, 45, 47]. Mills, et al. [45] found
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significant reductions in BP compared to baseline (p <
0.001), with 49% of participants reducing BP. Webb, et al.
[47] reported significant reductions in systolic BP and
diastolic BP. Tobi, et al. [43] did not report on BP find-
ings. BP was not reduced, compared to baseline within
one study [25].
BMI was also reported to have significantly reduced at
6 months, compared to baseline, however clinically, this
reduction was only a small amount [25].
Physical activity outcomes
Compared to baseline, two of the four RCTs showed in-
creased 7-day physical activity recall (7D PAR) scores
[25, 41], with two of these studies reporting significant
increases (p < 0.001). One study showed a significant in-
crease (p < 0.05) compared to control [41]. Murphy, et al.
[41] found significant increase in 7D PAR compared to
usual care. Standard ERS compared to a SDT-based
ERS found that both schemes significantly improved
self-reported PA, with no significant difference between
the two conditions [25].
Adherence
Seven out of ten studies recorded PA adherence to the
ERS programme. Compared to baseline, adherence to PA
prescribed increased in every study. Hanson, et al. [44]
reported significant differences (p < 0.001) along with
Murphy, et al. [41] and Webb, et al. [47] showing signifi-
cant differences of p < 0.05, and Tobi, et al. [43] also hav-
ing significant difference (p < 0.01). Littlecott, et al. [40]
found increased adherence to the prescription compared
to baseline, but not compared to usual care.
Duration and mode/type of exercise
Scheme’s duration was either 8–12 weeks [25, 42, 46, 47],
16 weeks [24, 40, 41] or 20–26 weeks [43–45], consisting
of a prescription of 1–2 exercise sessions per week. Nine
studies utilised one-to-one gym based PA as their main
mode of exercise, consisting of both cardiovascular and
resistance training activities. Two studies utilised group
based aerobic exercise sessions [45, 47], along with other
forms of PA including swimming and PA within studio
settings [45].
Results for mental health disorders’ sub-group
Five of the eight studies were RCTs [24, 25, 40, 41, 48].
Three of these compared ERS to usual care [40, 41, 48],
one compared ERS to a SDT-based ERS [25], or between
time points [24]. A further study used a SDT theory-based
exploratory design [46]. A retrospective study compared
adheres to non-adheres [43].
Anokye, et al. [42] reviewed the cost-effectiveness of
ERS overall. It was found that ERS was linked to a slower
increase in lifetime costs and benefits. ERS was found to
be 51–88% cost-effective. However, this was not only
related to mental health, but generic ERS.
MH disorder-related outcomes
Seven studies conducted research on individuals diag-
nosed with either mild or moderate depression/anxiety/
stress [24, 25, 40–42, 46, 48], with one study not giving
a detailed description of the mental health disorder [43].
Various psychosocial/psychological measures were
employed, with the Hospital Anxiety and Depression
Scale (HADS) being the most common. HADS anxiety
and depression were both decreased compared to baseline
[25, 41]. HADS depression showed lower scores compared
to HADS anxiety, with significant differences between
changes (p < 0.05) [25, 41]. Chalder, et al. [48] reported de-
creases in scores on the Beck Depression Inventory, com-
pared to both baseline and control. Behavioural Regulation
in Exercise Questionnaire (BREQ) scores also increased
compared to baseline, with one study showing signifi-
cant increase in results at completion (p < 0.01) and Sub-
jective Vitality Scale (SVS) scores also showing significant
increases at completion (p < 0.05) [46].
Physical activity outcomes
7D-PAR scores reported increases in PA at completion
compared to baseline [22, 25], and compared to control
[41, 48]. Significant increases (p < 0.001, p < 0.05) were
found in three of these studies [25, 41, 48].
Duration and mode/type of exercise
Scheme’s duration was either 8 weeks [48], 10–12 weeks
[25, 42, 46], 16 weeks [24, 40, 41] or 20–26 weeks long
[43], prescribing 1–2 exercise sessions weekly. Seven
schemes used one-to-one gym based PA, consisting of
both cardiovascular and resistance training activities.
Two studies utilised group based aerobic exercise ses-
sions [45, 47], along with other forms of PA including
swimming and PA within studio settings [45].
Results for musculoskeletal disorders’ sub-group
Research reviewing MSK disorders is extremely limited.
Within a complete search, only three articles showed
some relevance to the disorder, although, MSK measures
were not used. All three studies facilitated different designs
which included a RCT [49], an observational cohort study
[50], and a retrospective design [43].
MSK disorder-related outcomes
While these papers include referrals with MSK disorders,
uptake is low, along with no MSK disorder-specific
measures.
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Physical activity outcomes
Adherence to longer length schemes was better than
shorter length schemes [43]. When reported using an ob-
jective measure of adherence to the PA prescribed, rather
than subjective self-reported PA, longer schemes had a
significant difference on adherence to PA significant in-
crease p < 0.01) [43]. It was also suggested in the same
study that for every 10-year increase in age, odds of exer-
cise continuation increased by 21.8%.
Duration and mode/type of exercise
One study’s length was 12 weeks [51], with two studies of
20–26 weeks in length [49, 52]. They all utilised one-to-
one cardiovascular and resistance exercise with a prescrip-
tion of 1–2 sessions weekly. Additionally, one study
also incorporated group exercise sessions alongside the
one-to-one sessions [50].
Discussion
Summary of findings
The aim of this review was to examine the effects of
ERS within three populations: those with CV, MH, and
MSK disorders. Length of schemes, and mode and type
of exercise used with each sub-group, was reviewed due
to inconsistencies in previous research [2]. At present,
strong research is lacking to support ERS of 12-week
duration which are recommended by NICE [22], particu-
larly with respect to adherence to PA prescribed; evi-
dence suggests schemes do not tailor the mode and type
of exercise specifically to suit health disorders; and the
evidence to support ERS in specific disorders in relation
to adherence and improving health outcomes is poor
[2, 25, 28]. These two key variables will be discussed
further in detail.
Schemes have evidenced the effectiveness in CV
[25, 43, 47] and MH disorders [25, 41], but evidence
is lacking around MSK disorders. Duration and type of
ERS were elements to consider in terms of their impact
on outcomes. Overall, ERS resulted in significant reduc-
tions in BP [45, 47, 49, 50] and BMI [25, 47, 49, 50], and
increased adherence to the PA prescribed over time
[24, 40, 41, 43, 44, 49]. Self-reported PA levels also in-
creased [25, 41, 44, 49]. Prior to this review, a previous
systematic review suggested that separately reported
health outcomes relating to referral reason have not been
reported [2]. Within this review, the health disorder
sub-groups were individually analysed to review any
disorder-specific outcomes.
Within the CV sub-group, not all studies reported a
disorder-specific measure [24, 40–42, 44, 46]. To get a
true representation of any improvements made in the
CV sub-group, all studies should have reported on the
disorder-specific measures. Of those who did report on
CV-specific measures, all showed improvements in BP
and BMI [25, 45, 47].
Individuals referred for MH disorders, responded posi-
tively to either gym based exercise sessions or group aer-
obic exercise sessions. Disorder-specific measures such
as HADS showed that ERS significantly reduced anxiety
and depression scores [25, 41]. These were self-reported
measures of anxiety and depression. Other measures
were also reported, but most individuals referred tend to
have more than one health disorder [22], which can be
observed in the articles reviewed in Tables 1, 2 and 3.
MSK disorders have limited research of the effects of
ERS on disorder-specific outcomes. There are no direct
measures used to evaluate the effects of ERS on the
MSK disorders (such as measuring pain felt in the injured
area/range of movement/functional outcomes). Using mea-
sures such as Lower Extremity Functional Scale (LEFS),
Lower Limb Functional Index (LLFI) [53], McGill Pain
Questionnaire (MPQ) [52] or the Visual Analogue Scale
[54] could be tools which could more accurately measure
MSK disorders. At present one in five people consult a GP
about MSK pain each year. Support and treatment for
MSK chronic pain account for approximately 4.6 million
appointments per year [51]. If further research into the
effectiveness of ERS on MSK disorders was conducted
then, if effective, GP time could be reduced, saving time
and money for the NHS.
Length of schemes
ERS tend to conclude after a 10–12-week exercise
programme within England and Ireland [2, 23], although
longer length schemes offer more opportunity for individ-
uals to gain long term health benefits of PA [43, 44, 50].
NICE [22] who set out the guidelines for ERS, recommend
schemes last for at least 12 weeks. Research regarding lon-
ger length schemes is extremely limited. However, a previ-
ous study suggests that longer length schemes have been
beneficial for individuals with CV disease risk and MH
disorders, increasing PA levels whilst also being more
cost-effective [24]. Research relating to 12-week ERS sug-
gests that significant health outcomes and changes in PA
do not occur [27]. Many studies likely have employed
12-week schemes to meet the guidelines set out by NICE
[22]. However, if ERS scheme’s length recommendations
were increased by NICE, then it might be expected that
the implementation of ERS schemes would follow suit and
thus greater effects on health outcomes might occur.
Shorter-length ERS (8–10 weeks) did not produce the
same outcomes as schemes of longer lengths. For example,
a scheme of short length (8 weeks) did not have statistically
significant effects on physiological and psychosocial
outcomes for individuals referred for MH disorders
[48]. However, Webb, et al. [47] did find significant changes
in BP, through an 8-week long scheme for participants
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referred with CV disorders, although longer length schemes
produced better outcomes [43, 45]. Thus, it could be argued
that shorter length schemes should have the potential to im-
pact CV disorders, though longer schemes may be required
for MH disorders. Past research has showed that exercise
can have positive impacts on CV outcomes after only a
couple of weeks of participating in 30-min of regular vigor-
ous exercise [55]. Further research supports that four weeks
of aerobic and resistance exercise can improve blood
pressure, arterial stiffness and blood flow [56, 57]. It has
also been reported that diastolic and systolic blood pres-
sure can be reduced after one exercise session, and remain
low for up to 90 min’ post-exercise session [58–60]. Thus,
could support the use if 8-week ERS for participants with
CV conditions, in the improvement of CV-specific health
outcomes such as systolic and diastolic blood pressure.
Mid length schemes (11–19 weeks) did show signifi-
cant improvement in the conditions examined. As noted,
NICE [22] schemes have stated that schemes should be
at least 12 weeks in length. Various other clinical and
traditional exercise programmes are often longer than
12 weeks [24, 61–63] and demonstrate greater efficacy
for improving health conditions [47]. Therefore, ERS
guidelines should perhaps be adapted to match this.
Compared with an 8-week ERS, Webb, et al. [47] found
that within an 8-week community-based outdoor exer-
cise programme, participants achieved higher intensities
of effort resulting in pronounced beneficial effects on
health including: significant CV disease risk-lowering;
reduced blood pressure; arterial stiffness; and blood
lipids. Increasing the length of ERS may permit them to
produce results more comparable with other exercise
and PA interventions. Further, consideration of the mode
of exercise, could improve the effectiveness of ERS. To
support this, Duda, et al. [25] found that there were no
significant changes in BP in schemes of 10–12 weeks
in length. This may be due to other cofounding influ-
ences which may have affected blood pressure not
allowing it to reduce in the short term, including medi-
cation [64]. However, combinations of longer duration
exercise interventions with medication may potentially
provide a more stable and positive effect on blood
pressure [65].
Studies of schemes following the NICE [22] recom-
mended length of 12 weeks found that, compared to no
intervention, self-reported PA levels did not differ [49].
This could suggest that 12 weeks is not long enough to
initiate changes in PA which are perceivable by partici-
pants. Longer length schemes may improve self-reported
PA. However, schemes of this length had some impact
on reducing sedentary behaviours, but it was suggested
that this was unlikely to be sustained and lead to long
term health benefits such as weight loss, sustained re-
duced BP, and decreased BMI [49].
Longer-length schemes (20+ weeks) have been shown
to be beneficial in improving various health outcomes
and aid healthier behaviours [7, 45, 50]. All longer-length
schemes reviewed had positive impacts on health, redu-
cing BP and BMI [26], improving PA levels [24] and in-
creasing adherence to the prescription [43–45, 50]. At
present, guidelines use 12-week ERS as a basis for pro-
viders to follow [22] whereas a change in guidelines to
introduce longer length schemes might result in more
providers delivering ERS of such length in the UK and
produce better health outcomes as well as cost savings
for the NHS [24].
Type and mode of exercise
The most common type of exercise employed in ERS was
one-to-to one supervised gym based exercise sessions, in-
corporating both resistance and cardiovascular exercise
for all health conditions [24, 25, 41, 43, 44, 46]. Individuals
referred for CV disorders, who incorporate both resistance
and aerobic exercises into their prescription, saw greater
improvements in CV health which is supported by past
research [66, 67]. This is in line with results found within
studies included in this review [25, 45, 47].
MH disorders also improved significantly when indi-
viduals took part in aerobic and resistance training gym
based exercise. Scores relating to depression and anxiety
had all improved [24, 25, 41, 43, 46]. Physical activity
levels had also increased. This could suggest that gym
based exercise sessions incorporating aerobic and resist-
ance exercise are best suited in reducing MH disorders.
Indeed, a recent meta-analysis supports the use of resist-
ance exercise in treatment of anxiety [12] while previous
reviews also support the benefits of aerobic training [68].
Both are clearly effective, yet may exert specific effects
upon MH outcomes. Thus, the combined approach may
be best suited for ERS in MH disorders.
There is very limited research on ERS with MSK disor-
ders, therefore it is difficult to compare the results from
this review to past literature. Only three articles were
found to be relevant for this review for this population
[46, 49, 50]. All comprised of predominantly one-to-one
exercise sessions, and all reported increases in adherence
to PA prescribed across time. Unfortunately, none of the
studies included any outcomes related to the patient’s
MSK disorders such as pain or disability. Considering
that all also utilised similar interventions it is therefore
difficult to discern specifically the comparative efficacy
of different types of ERS in MSK disorders. However,
there is evidence to suggest that, similarly to other disor-
ders, using both aerobic and resistance exercises do im-
prove musculoskeletal disorders including osteoarthritis
of the knee [69].
Aerobic exercise sessions were solely the mode of
some schemes [40, 48]. However, as has been shown,
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prescriptions of exercise that solely focus on aerobic ex-
ercise may be less efficacious as combined approaches.
Resistance training exerts a wide range of benefits
alongside aerobic training [70, 71]. Additionally, aer-
obic exercise-only ERS present its own issues such as
lack of efficacy as typically employed in reducing or
stopping lean body mass loss, and associated loss in
resting metabolic rate per decade affiliated with normal
ageing [72]. That the majority of research has focused
upon the health benefits gained from aerobic training has
made this mode of exercise a primary focal point within
PA guidelines according to literature [73]. However, it has
been argued that resistance training based interventions
should have a greater emphasis in public health ap-
proaches [74].
At present NICE guidelines [22] do not advise on the
type and mode of exercise that should be employed
within ERS, though the majority of studies here show that
one-to-one gym based exercise sessions employing both
aerobic and resistance training are effective. Tailoring the
type and mode of exercise to be disorder-specific could
also influence adherence and health outcomes. The evi-
dence reviewed here suggests that a combining both
aerobic and resistance exercise is effective across a
range of disorders. However, there is a lack of research
directly comparing different ERS utilising different exer-
cise approaches. Some individuals may also be referred for
multiple disorders, and this may need an entirely different
approach. Usually, a referral is made for one health dis-
order, but if an individual is referred for more than one
disorder, then a more nuanced exercise programme may
be required. This may also mean that the scheme’s length
needs adjusting to suit the amount of disorders referred
for. Further research is required to analyse the type and
mode of exercise prescribed dependant on the disorders
and health outcomes upon completion.
Implications for future research and clinical practice
The usual length of schemes in most ERS is 12 weeks long
[22]. Research within this review has found that longer
schemes (20 weeks+) may provide better effects on adher-
ence to the prescription and health outcomes [43, 44, 50].
This conclusion suggests that recommendations set out
by NICE [22] might benefit from being updated to empha-
sise the importance of longer schemes. Indeed, as noted,
longer schemes have also been shown to be more cost ef-
fective [24]. A key challenge for future research is to iden-
tify ways to maximise uptake and improve adherence to
PA prescribed until completion across all schemes.
At present, ERS are not meeting several standards set
out by NICE including: referral of individuals who are
sedentary/inactive but otherwise healthy; incorporate be-
haviour change into individual approaches; agreeing
goals and sticking to action plans with regular follow
ups with no-shows; and tailoring the intervention to in-
dividual needs and develop coping plans to prevent re-
lapse. At present, though often one-to-one sessions are
employed, schemes are typically generic and not perso-
nalised to suit individuals and their health disorders
specifically. One-to-one gym based exercise sessions
can potentially be tailored to individual needs of each
participant and health disorder. However, within this
review, there was no information given within studies
on how programmes were tailored to suit each partici-
pant, or if they were at all. At present, NICE [22] have
not set any guidelines on the type and mode of exercise
which is to be administered, let alone disorder-specific
exercise guidelines. Broadly the results of this review
suggest that combined approaches of both cardiovascu-
lar and resistance exercises are effective across disor-
ders. Yet there is little research directly comparing different
approaches, or comparing generic interventions to those
with specific individualisation. By tailoring programmes to
suit each patient, ERS could address some of the barriers
which some patients report stop them from adhering
to schemes, including unfamiliar environment, quality
of interaction with exercise provider, boredom, exercise
preferences, poor record keeping, and clinical disorder [21].
Economic impact of ERS was reported in one study
[42]. Results show that for sedentary individuals with
CVD, and sedentary individuals with a MH disorder, the
estimated cost per quality-adjusted life year (QALY) was
£12,834 and £8414 respectively. Benefits and incremental
lifetime costs linked with ERS were found to be sensitive
to variations in the relative risk of ERS costs and becom-
ing physically active. ERS is more expensive compared to
usual care, due to the additional mean lifetime costs of
£170 per individual, although, it is more effective in lead-
ing to a lifetime mean QALY gain of 0.008 per individual.
Although schemes need to be cost-effective, future train-
ing of exercise referral instructors could be adapted to im-
prove exercise prescriptions with updated evidence-based
guidelines. This may reduce the burden of cost on ERS, as
instructors will be more equipped to prescribe exercise
which may have greater effects on health outcomes. An
evaluation of a scheme in Belfast found that they calcu-
lated a return of approximately £7 for every £1 invested
into their Healthwise Physical Activity Referral Programme
[75]. Further, Anokye, et al. [42] reviewed the cost-ef-
fectiveness of ERS. It was found that ERS was linked to
a slower increase in lifetime costs and benefits. ERS
was found to be 51–88% cost-effective.
Other identified issues within this review include that
control interventions are often not explained in detail
[25, 40, 43, 48, 50, 64]. They must distinctly differ from
ERS, and be explained in detail, in order to examine
comparative effectiveness. Another identified issue, which
may also provide evidence for NICE policies is that
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health-economic evaluations are often not incorpo-
rated into studies to review the cost-effectiveness of
the schemes alongside the effectiveness on health out-
comes. Evidence of cost-effectiveness is also required
to understand the wider benefits of GPs referring pa-
tients to ERS reducing burdens on the NHS.
Conclusion
The current review present an updated overview of ERS in
the UK and provides insights to aid in guideline revisions
and policy development, in addition to identifying area’s
where research is still required. It can be concluded
that longer length schemes may produce more significant
positive effects on health outcomes than shorter schemes.
These effects include reduced BP and BMI [45, 50], im-
proved physical activity levels [7] and increasing adher-
ence to the PA prescribed over time [43–45, 50]. At
present, NICE [22] recommend schemes last for 12 weeks,
but it appears that this guidance should be updated to in-
crease length of schemes. This in turn may improve ad-
herence to exercise and physical activity. The gap between
research and policy needs to be bridged. Further research
which is required to examine the comparative effects of
specific types and modes of exercise, and in the improve-
ment of specific health disorders. Such evidence might
help produce predictive models to allow GPs to identify
the best referral pathways for patients. Alongside a pre-
dictive model, an economic evaluation of ERS, compared
to usual care specifically designed around each disorder
type, could also help to inform policy decisions.
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